Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified

Acta Obstetricia et Gynecologica Scandinavica

Volumn 86, Issue 2, 2007, Pages 167-171

  Widlund, Kjerstin Ferm ^a   Gottvall, Tomas ^b  

^a VRINNEVI HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amniocentesis; Amniotic fluid alpha Fetoprotein; Neural tube defects; Prenatal diagnosis; Screening

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AMNIOCENTESIS; AMNION FLUID ANALYSIS; ANAMNESIS; ANEUPLOIDY; ANXIETY; ARTICLE; FALSE POSITIVE RESULT; FEMALE; FIRST TRIMESTER PREGNANCY; GENETIC SCREENING; HEALTH CARE POLICY; HUMAN; MATERNAL AGE; MATERNITY WARD; MEDICAL ASSESSMENT; NEURAL TUBE DEFECT; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUESTIONNAIRE; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; SWEDEN;

ADULT; ALPHA-FETOPROTEINS; AMNIOCENTESIS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MATERNAL AGE; NEURAL TUBE DEFECTS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SWEDEN;

EID: 33847003377     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340601048012     Document Type: Article

References (17)

1. Brock DJH, Sutcliffe RG. Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida. Lancet. 1972;2:197-9.
2. United Kingdom Collaborative Study on Alpha-fetoprotein in Relation to Neural Tube Defect. Amniotic fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Lancet 1979;i: 651-62.
3. Goldberg MF, Oakley GP. Interpreting elevated amniotic fluid alpha-fetoprotein levels in clinical practice: use of predictive value positive concept. Am J Obstet Gynecol. 1979;133:126-32.
4. Kimball ME, Milunsky A, Alpert E. Prenatal diagnosis of neural tube defects. III. A re-evaluation of the alpha-fetoprotein assay. Obstet Gynecol. 1977;49:532-6.
5. Fisher NL, Luthy DA, Peterson A, Karp LE, Williamson R, Cheng E. Prenatal diagnosis of neural tube defects: predictive value of AF-AFP in a low-risk population. Am J Med Genet. 1981;9:201-9.
6. Shields LE, Uhrich SB, Komarniski CA, Wener MH, Winter TC. Amniotic fluid alpha-fetoprotein determination at the time of genetic amniocentesis: has it outlived its usefulness? J Ultrasound Med. 1996;15:735-9.
7. Mandruzzato GP, Fischer-Tamaro L, De Seta F, D'Ottavio G, Rustico MA, Conoscenti G. Does amniotic fluid alpha-fetoprotein have diagnostic or prognostic value at the time of second midtrimester genetic amniocentesis? Fetal Diagn Ther. 2002;17:147-52.
8. Silver RK, Leeth EA, Check IJ. A reappraisal of amniotic fluid α-fetoprotein measurement at the time of genetic amniocentesis and midtrimester ultrasonography. J Ultrasound Med. 2001;20:631-7.
9. Routine ultrasound examination during pregnancy. The Swedish Council on Technology Assessment in Health Care, SBU-rapport nr 139.
10. Nicolaides KH, Campell S, Gabbe SG, Guidetti R. Ultrasound screening for spina bifida: cranial and cerebellar signs. Lancet ; 2. 1986;12:72-4.
11. Van den Hof MC, Nicolaides KH, Campell J, Campell S. Evaluation of lemon and banana signs in one hundred thirty fetuses with open spina bifida. Am J Obstet Gynecol. 1990;162:322-7.
12. Coombes E, Moody B, Howard J. Comparison of a time-resolved fluoroimmunoassay with a solid phase immunoradiometric assay for the measurement of alphafetoprotein in amniotic fluid. J Automatic Chem. 1987;9:129-31.
13. Tabor A, Philip J, Madsen M, Bang J, Obel EB, Nörgaard-Pedersen B. Randomized controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet. 1986;i:1287-93.
14. Schnittger A, Kjessler B. The outcome of a uniform program for alpha-fetoprotein screening in early pregnancy in seven regions in Sweden. Acta Obstet Gynecol Scand Suppl. 1984;119:9-23.
15. Crandall BF. Alpha-fetoprotein: a review. Crit Rev Clin Lab Sci. 1981;15:127-84.
16. Pandya PP, Snijders RJ, Johnson SP, De Lourdes Brizot M, Nicolaides KH. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol. 1995;102:957-62.
17. Hogge WA, Thiagarajah S, Ferguson JE, Schnatterly PT, Harbert GM. The role of ultrasonography and amniocentesis in the evaluation of pregnancies at risk of neural tube defects. Am J Obstet Gynecol. 1989;161:520-4.